3 Top Hyderabad-based Stocks to Watch for Future Multibagger Potential: Divi's Labs, Laurus Labs and NMDC

Hyderabad-based stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Divi's Labs, Laurus Labs and NMDC meet that test, with market caps from Rs 62,352 crore to Rs 2.40 lakh crore and Divi's Labs offering the largest market cap at Rs 2,39,982 crore. Hyderabad is a global hub for pharma ingredients, and it also hosts India's largest iron ore miner.

This list covers listed companies headquartered in Hyderabad, Telangana, with complete, verifiable financials, ranked by market capitalisation. Not every name here is a largecap, so the list takes the leading companies of the sector by market capitalisation. Investors screening Hyderabad-based stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 16 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Hyderabad-based Stocks and Why Do They Attract Multibagger Interest?

Hyderabad-based stocks are shares of companies headquartered in Hyderabad. Two make active ingredients and custom molecules for global drug makers, while the third mines iron ore for India's steel industry.

Global drug makers outsource ingredient supply to reliable partners, and India's steel sector needs ore for growth. Companies with strong margins, large capacity and good returns are the ones investors compare in Hyderabad-based stocks.

Hyderabad-based Stocks at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 16 October 2026. NMDC combines the lowest PE of the group, 8.36, with the highest return on equity, 21.87%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Divi's Laboratories	9,144.50	2,39,982	82.05	36.42	15.32%	0.00	5,647.50 to 9,740.00
Laurus Labs	2,060.10	1,09,143	100.10	36.42	16.77%	0.48	864.70 to 2,085.90
NMDC	71.69	62,352	8.36	10.06	21.87%	0.19	70.10 to 97.49

Divi's Labs: Debt-to-Equity of 0.00

Divi's Laboratories makes active pharmaceutical ingredients and intermediates and runs a large custom synthesis business for global drug companies. It reported FY26 revenue of Rs 11,067 crore, up 13.95% year on year, and net profit of Rs 2,568 crore, up 17.21%. Revenue has compounded at 5.09% a year since FY22. Operating margin was 36.70% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

In the June 2026 quarter, revenue rose 24.32% to Rs 3,144 crore and net profit grew 65.50% to Rs 902 crore. The share price has gained 71.04% over five years and 38.43% over the past year. Foreign investors raised their holding from 19.39% in September 2025 to 20.38% in September 2026. The stock trades at a PE of 82.05 against an industry PE of 36.42, with a return on equity of 15.32%.

Laurus Labs: Revenue Up 22.01% in FY26

Laurus Labs makes active pharmaceutical ingredients and formulations and offers contract development and manufacturing services. It reported FY26 revenue of Rs 6,867.85 crore, up 22.01% year on year, and net profit of Rs 889.85 crore, up 151.08%. Revenue has compounded at 8.53% a year since FY22. Operating margin was 26.90% in FY26. The debt-to-equity ratio is 0.48.

The stock trades at a PE of 100.10 against an industry PE of 36.42, with a return on equity of 16.77%. In the June 2026 quarter, revenue rose 28.83% to Rs 2,035.49 crore and net profit grew 124.73% to Rs 361.99 crore. The share price has gained 221.40% over five years and 137.53% over the past year. Domestic institutions raised their holding from 11.94% in June 2025 to 13.74% in June 2026.

NMDC: Revenue Up 31.61% in FY26

NMDC is a government-owned miner and India's largest iron ore producer. It reported FY26 revenue of Rs 33,559.27 crore, up 31.61% year on year, and net profit of Rs 7,415.37 crore, up 13.39%. Revenue has compounded at 5.90% a year since FY22. Operating margin was 33.51% in FY26. The debt-to-equity ratio is 0.19.

In the June 2026 quarter, revenue rose 1.47% to Rs 7,142.54 crore and net profit grew 1.94% to Rs 2,005.71 crore. Foreign investors raised their holding from 12.21% in June 2025 to 13.59% in June 2026. The stock trades at a PE of 8.36 against an industry PE of 10.06, below the sector average, with a return on equity of 21.87%. The dividend yield is 4.94%.

Hyderabad-based Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these Hyderabad-based stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	Latest Quarter Revenue Growth	Operating Margin (Latest Quarter)
Divi's Labs	11,067	2,568	13.95%	5.09%	24.32%	42.82%
Laurus Labs	6,867.85	889.85	22.01%	8.53%	28.83%	31.95%
NMDC	33,559.27	7,415.37	31.61%	5.90%	1.47%	41.43%

Check the Univest Screener for live data on these Hyderabad-based stocks

Institutional Holding in Divi's Labs, Laurus Labs and NMDC

Institutional holding shows who is backing these Hyderabad-based stocks alongside the promoter. The table uses the latest reported quarter for each. Laurus Labs has the deepest institutional backing, with FII and DII together holding 41.74% as of June 2026. Domestic institutions increased their holding over the past year in Laurus Labs (from 11.94% to 13.74%).

Stock	Promoter	FII	DII	Public	Quarter
Divi's Labs	51.88%	20.38%	19.17%	8.58%	September 2026
Laurus Labs	27.47%	28.00%	13.74%	30.78%	June 2026
NMDC	60.79%	13.59%	13.81%	11.80%	June 2026

Risks to Weigh in Hyderabad-based Stocks

Being careful with Hyderabad-based stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Pharma ingredient earnings depend on global customer orders.
• Mining earnings depend on ore prices.
• Valuation: Laurus Labs trades at a PE of 100.10 against an industry PE of 36.42, so earnings need to keep growing to support the price.
• Concentration: Holding all 3 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Hyderabad-based Stocks

Picking from Hyderabad-based stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (10.06 to 36.42) and ask whether the growth rate justifies any gap.
3. Track revenue growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Divi's Labs, Laurus Labs and NMDC live prices.

Conclusion

Among Hyderabad-based stocks, Divi's Labs stands out for the largest market cap at Rs 2,39,982 crore, Laurus Labs for the biggest five-year price gain at 221.40% and NMDC for the highest return on equity at 21.87%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing Hyderabad-based stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Hyderabad-based Stocks to Watch

Which are the best Hyderabad-based stocks to watch for multibagger potential?

Ans. Divi's Labs, Laurus Labs and NMDC are the 3 names this list highlights, with market caps of Rs 2,39,982 crore, Rs 1,09,143 crore and Rs 62,352 crore respectively. Divi's Labs is notable for the largest market cap at Rs 2,39,982 crore. Laurus Labs stands out for the biggest five-year price gain at 221.40%. NMDC offers the highest return on equity at 21.87%. These are watchlist names for Hyderabad-based stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is NMDC a good stock for long-term investors?

Ans. NMDC has a return on equity of 21.87%, a PE of 8.36 against an industry PE of 10.06 and a market cap of Rs 62,352 crore. FY26 revenue rose 31.61%, and June 2026 quarter net profit grew 1.94%. Long-term returns in Hyderabad-based stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Laurus Labs become a multibagger from here?

Ans. Laurus Labs has already gained 221.40% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in Hyderabad-based stocks requires earnings to keep growing faster than the market for several years. FY26 revenue rose 22.01%, and June 2026 quarter net profit grew 124.73%. At a PE of 100.10 against an industry PE of 36.42, valuation should be checked against that growth before investing.

What is the market cap of Divi's Labs, Laurus Labs and NMDC?

Ans. As of 16 October 2026, Divi's Labs has a market cap of Rs 2,39,982 crore, Laurus Labs has a market cap of Rs 1,09,143 crore and NMDC has a market cap of Rs 62,352 crore. Divi's Labs is the largest of the group. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on Hyderabad-based stocks.

What are the risks of investing in Hyderabad-based stocks?

Ans. The main risks are changes in customer orders, regulatory checks of plants and ore price swings. Companies with long customer relationships and low costs handle these better. Laurus Labs trades at a PE of 100.10 against an industry PE of 36.42, so earnings growth needs to hold up.

Why is Laurus Labs trading at a PE of 100.10?

Ans. Laurus Labs' PE of 100.10 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 16.77%, latest-quarter profit growth of 124.73% and FY26 revenue growth of 22.01%, which also means the stock is more sensitive if growth slows. Investors in Hyderabad-based stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Divi's Labs, Laurus Labs and NMDC?

Ans. As of the latest reported quarter, FII and DII together hold 39.55% of Divi's Labs (20.38% and 19.17%), 41.74% of Laurus Labs (28.00% and 13.74%) and 27.40% of NMDC (13.59% and 13.81%). Rising institutional holding is a useful signal in Hyderabad-based stocks, though it should be read with earnings trends rather than on its own.